• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

A Decade in the Anti-Obesity Arena

Commentary
Podcast

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.

In this episode of the Pharmaceutical Executive Podcast, Currax Pharmaceuticals CEO, George Hampton discusses:

  • Contrave
  • What patient success has looked like
  • How different kinds of therapies perform and fit in the current business landscape
  • Ethical and regulatory problems for weight loss companies like WW, Noom, and Ro present
  • How can access to these weight loss drugs help the obesity epidemic
  • and much more!
Recent Videos
Related Content